Literature DB >> 15953503

Effective care of patients with type 2 diabetes and dyslipidemia: a nurse's perspective.

Maria Adiseshiah1.   

Abstract

By 2030, it is predicted that type 2 diabetes will affect 4.4% of the world's population, an estimated 366 million individuals. Diabetic dyslipidemia is a modifiable risk factor for cardiovascular disease, which is a major cause of premature mortality in type 2 diabetes. The management of diabetic dyslipidemia requires a multidisciplinary approach and the role of the nurse within the healthcare team is pivotal. Their broad remit positions nurses not only at the forefront of care, where they are well placed to recognize the clinical signs of the condition, but also as patient advisor, counselor, educator, monitor and motivator during the continuum of care. Poor concordance is a common problem for patients receiving multiple medications. Educating the patient about the importance of lifestyle change, and ensuring that lifestyle and pharmacological interventions are sustained are important components of effective care. Choosing therapies that enable patients to reach their treatment goals with a simple dosage regimen may also help to maximize patient concordance. Nurses must remain up to date with treatment options and management guidelines in order that they can communicate relevant information to patients, empowering them to make informed decisions about their health. Specific, measurable, achievable, relevant and time-specific (SMART) goals should be set for each patient. This form of individualized care, in which the patient becomes fully engaged with their treatment plan and personal goals appear attainable, may help to reduce the projected burden of type 2 diabetes and its complications on healthcare services in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953503     DOI: 10.1016/j.diabres.2005.03.017

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Allometric prediction of the human pharmacokinetic parameters for naveglitazar.

Authors:  Preeti Ahlawat; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

2.  mHealth Tools for the Self-Management of Patients With Multimorbidity in Primary Care Settings: Pilot Study to Explore User Experience.

Authors:  Anum Irfan Khan; Ashlinder Gill; Cheryl Cott; Parminder Kaur Hans; Carolyn Steele Gray
Journal:  JMIR Mhealth Uhealth       Date:  2018-08-28       Impact factor: 4.773

Review 3.  Partnering with diabetes educators to improve patient outcomes.

Authors:  Sandra D Burke; Dawn Sherr; Ruth D Lipman
Journal:  Diabetes Metab Syndr Obes       Date:  2014-02-12       Impact factor: 3.168

4.  Breaking Barriers to Effective Type 2 Diabetes Management: Findings from the use of the OPTIMA© Questionnaire in Clinical Practice.

Authors:  André Grimaldi; Alfred Penfornis; Silla Consoli; Bruno Falissard; Elisabeth Eymard; Paul Williams; Sylvie Dejager
Journal:  Adv Ther       Date:  2016-05-18       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.